Abstract
Entamoeba histolytica, is a human pathogen which is endemic in tropical areas. The most common extra-intestinal locations for disease after the liver are pleural and pulmonary. Although the outcome of pleural and pulmonary amoebiasis is generally favourable, it is important to note that a significant proportion of patients do develop pleural and pulmonary after-effects. We report a case of pleural and pulmonary amoebiasis where the evolution of a massive pleural effusion and 3 associated liver abscesses was spectacular. The surgical management of pleural, pulmonary and liver amoebiasis is discussed.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adult
-
Animals
-
Anti-Bacterial Agents / therapeutic use
-
Antiprotozoal Agents / therapeutic use
-
Diagnosis, Differential
-
Drug Therapy, Combination
-
Entamoeba histolytica* / isolation & purification
-
Entamoebiasis / diagnosis*
-
Entamoebiasis / drug therapy
-
Entamoebiasis / parasitology
-
Humans
-
Liver Abscess, Amebic / diagnosis*
-
Liver Abscess, Amebic / drug therapy
-
Liver Abscess, Amebic / parasitology
-
Lung Diseases, Parasitic / diagnosis*
-
Lung Diseases, Parasitic / drug therapy
-
Lung Diseases, Parasitic / parasitology
-
Male
-
Metronidazole / therapeutic use
-
Pleural Effusion / diagnosis
-
Pleural Effusion / parasitology*
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Antiprotozoal Agents
-
Metronidazole